Gerber Kawasaki Wealth & Investment Management’s AstraZeneca AZN Stock Holding History

Gerber Kawasaki Wealth & Investment Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,931	Closed	-$381K	–	368
2026 Q1	$381K	Buy	1,931 +364	+23%	+$70.2K	0.01%	252
2025 Q4	$288K	Sell	1,567 -28	-2%	-$4.91K	0.01%	289
2025 Q3	$245K	Buy	1,595 +8	+0.5%	+$1.21K	0.01%	293
2025 Q2	$222K	Buy	1,587 +79	+5%	+$11.1K	0.01%	288
2025 Q1	$222K	Buy	+1,508	New	+$218K	0.01%	278
2024 Q4	–	Sell	-1,304	Closed	-$203K	–	285
2024 Q3	$203K	Buy	+1,304	New	+$210K	0.01%	277
2021 Q4	–	Sell	-2,129	Closed	-$255K	–	346
2021 Q3	$255K	Buy	2,129 +93	+5%	+$10.8K	0.03%	159
2021 Q2	$243K	Buy	+2,036	New	+$223K	0.02%	217

Other funds holding AZN

EPGL

Evelyn Partners Group Ltd London $46.9B AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Amundi Paris, France $413B AUM 44.57% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Gerber Kawasaki Wealth & Investment Management's AZN Position: Q2 2026 in Review

Gerber Kawasaki Wealth & Investment Management sold out of AstraZeneca (AZN) in Q2 2026, closing a stake of 1,931 shares — an estimated $381K sold.

Gerber Kawasaki Wealth & Investment Management first reported a position in AZN in Q2 2021 and held it in 8 quarters. The position peaked at $381K in Q1 2026. 1,149 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Gerber Kawasaki Wealth & Investment Management reported no remaining AstraZeneca position as of Q2 2026 after selling out during the quarter.
Gerber Kawasaki Wealth & Investment Management sold 1,931 AstraZeneca shares in Q2 2026, an estimated $381K.
Gerber Kawasaki Wealth & Investment Management first reported a position in AstraZeneca in Q2 2021 and held it in 8 quarters.
Gerber Kawasaki Wealth & Investment Management's AstraZeneca position peaked at $381K in Q1 2026.
1,149 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Gerber Kawasaki Wealth & Investment Management's 13F filing for Q2 2026, filed 7 Aug 2026.